Abstract

The potent and selective Gq protein inhibitor depsipeptide FR900359 (FR), originally discovered as the product of an uncultivable plant endosymbiont, is synthesized by a complex biosynthetic system comprising two nonribosomal peptide synthetase (NRPS) assembly lines. Here we characterize a cultivable bacterial FR producer, enabling detailed investigations into biosynthesis and attachment of the functionally important FR side chain. We reconstitute side chain assembly by the monomodular NRPS FrsA and the non-heme monooxygenase FrsH, and characterize intermolecular side chain transesterification to the final macrocyclic intermediate FR-Core, mediated by the FrsA thioesterase domain. We harness FrsA substrate promiscuity to generate FR analogs with altered side chains and demonstrate indispensability of the FR side chain for efficient Gq inhibition by comparative bioactivity, toxicity and docking studies. Finally, evolution of FR and side chain biosynthesis is discussed based on bioinformatics analyses. Side chain transesterification boosts potency and target affinity of selective Gq inhibitor natural products.

FR900359 (FR) is a Gq protein inhibitor depsipeptide isolated from an uncultivable plant endosymbiont and synthesized by non-ribosomal peptide synthetases. Here, the authors discover a cultivable bacterial FR producer and show that FrsA thioesterase domain catalyses intermolecular transesterification of the FR side chain to the depsipeptide core during biosynthesis, improving Gq inhibition properties.

Details

Title
Thioesterase-mediated side chain transesterification generates potent Gq signaling inhibitor FR900359
Author
Hermes Cornelia 1   VIAFID ORCID Logo  ; Richarz René 1 ; Wirtz, Daniel A 1 ; Patt, Julian 1   VIAFID ORCID Logo  ; Hanke Wiebke 1 ; Kehraus Stefan 1 ; Voß, Jan Hendrik 2   VIAFID ORCID Logo  ; Küppers, Jim 2 ; Ohbayashi Tsubasa 3 ; Namasivayam Vigneshwaran 2   VIAFID ORCID Logo  ; Alenfelder Judith 1 ; Inoue Asuka 4 ; Mergaert, Peter 5   VIAFID ORCID Logo  ; Gütschow, Michael 2 ; Müller, Christa E 2   VIAFID ORCID Logo  ; Kostenis Evi 1   VIAFID ORCID Logo  ; König, Gabriele M 1 ; Crüsemann Max 1   VIAFID ORCID Logo 

 University of Bonn, Institute of Pharmaceutical Biology, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300) 
 University of Bonn, Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, Bonn, Germany (GRID:grid.10388.32) (ISNI:0000 0001 2240 3300) 
 University of Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France (GRID:grid.457334.2); Institute for Agro-Environmental Sciences, National Agriculture and Food Research Organization (NARO), Tsukuba, Japan (GRID:grid.416835.d) (ISNI:0000 0001 2222 0432) 
 Tohoku University, Graduate School of Pharmaceutical Sciences, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943) 
 University of Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France (GRID:grid.457334.2) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2476251119
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.